Literature DB >> 34240162

Rare Causes of Hypercalcemia: 2021 Update.

Yasaman Motlaghzadeh1, John P Bilezikian2, Deborah E Sellmeyer1.   

Abstract

CONTEXT: Primary hyperparathyroidism and malignancy are the etiologies in 90% of cases of hypercalcemia. When these entities are not the etiology of hypercalcemia, uncommon conditions need to be considered. In 2005, Jacobs and Bilezikian published a clinical review of rare causes of hypercalcemia, focusing on mechanisms and pathophysiology. This review is an updated synopsis of rare causes of hypercalcemia, extending the observations of the original article. EVIDENCE ACQUISITION: Articles reporting rare associations between hypercalcemia and unusual conditions were identified through a comprehensive extensive PubMed-based search using the search terms "hypercalcemia" and "etiology," as well as examining the references in the identified case reports. We categorized the reports by adults vs pediatric and further categorized the adult reports based on etiology. Some included reports lacked definitive assessment of etiology and are reported as unknown mechanism with discussion of likely etiology. EVIDENCE SYNTHESIS: There is a growing understanding of the breadth of unusual causes of hypercalcemia. When the cause of hypercalcemia is elusive, a focus on mechanism and review of prior reported cases is key to successful determination of the etiology.
CONCLUSIONS: The ever-expanding reports of patients with rare and even unknown mechanisms of hypercalcemia illustrate the need for continued investigation into the complexities of human calcium metabolism.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  1,25 dihydroxyvitamin D; PTHrP; calcitriol; ectopic PTH; hypercalcemia

Mesh:

Substances:

Year:  2021        PMID: 34240162     DOI: 10.1210/clinem/dgab504

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia.

Authors:  Carolina Rodrigues Tonon; Taline Alisson Artemis Lazzarin Silva; Filipe Welson Leal Pereira; Diego Aparecido Rios Queiroz; Edson Luiz Favero Junior; Danilo Martins; Paula Schimdt Azevedo; Marina Politi Okoshi; Leonardo Antonio Mamede Zornoff; Sergio Alberto Rupp de Paiva; Marcos Ferreira Minicucci; Bertha Furlan Polegato
Journal:  Med Sci Monit       Date:  2022-02-26

2.  Double Trouble: A Unique Case of Hypercalcemia Caused by Two Underlying Etiologies.

Authors:  Eloy E Ordaya; Jose Arriola-Montenegro; Liliana Arriola-Montenegro; Mel L Anderson
Journal:  Cureus       Date:  2022-01-10

Review 3.  Calcitriol-Mediated Hypercalcemia, Somatostatin Receptors Expression and 25-Hydroxyvitamin D3-1α- Hydroxylase in GIST Tumors.

Authors:  Yiraldine Herrera-Martínez; María José Contreras González; Sergio Pedraza-Arévalo; Maria Del Carmen Guerrero Martínez; Ángela Rodrigo Martínez; Alberto González Menchen; Maria Angeles Blanco Molina; Maria Angeles Gálvez-Moreno; Alberto L Moreno-Vega; Raúl M Luque; Aura D Herrera-Martínez
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-26       Impact factor: 5.555

4.  Hypercalcemia, Acute Kidney Injury, and Metabolic Alkalosis.

Authors:  Faten Aqeel; Jennifer Del Castillo; Bernard G Jaar; Mohamad Hanouneh
Journal:  Case Rep Nephrol       Date:  2022-04-06

5.  Occult Pulmonary Neuroendocrine Tumor Causing Severe Hyperparathyroidism: Diagnostic Challenges and Clinical Outcomes.

Authors:  Aaron Yazdian; Jeffrey Minuk; Gregory Hemenway; Neelam Upadhyaya; Cherie Lisa Vaz
Journal:  AACE Clin Case Rep       Date:  2022-06-18

6.  Sarcoid-like Lung Disease as a Reaction to Silica from Exposure to Bentonite Cat Litter Complicated by End-Stage Renal Failure-A Case Report.

Authors:  Joanna Hubska; Urszula Shahnazaryan; Marek Rosłon; Benedykt Szczepankiewicz; Kostiantyn Nikiforow; Marcin Pisarek; Małgorzata Barnaś; Urszula Ambroziak
Journal:  Int J Environ Res Public Health       Date:  2022-10-09       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.